Skip to content

Clinical trials

Phase 2 Metabolism, Inborn Errors trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Phase: Phase 2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20081
20091
20111
20141
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Masonic Cancer Center, University of Minnesota3
National Center for Research Resources (NCRR)3
Alexion Pharmaceuticals, Inc.1
Children's Hospital Medical Center, Cincinnati1
Fred Hutchinson Cancer Center1
HemoShear Therapeutics1
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
Kastle Therapeutics, LLC1
New York Medical College1
University of California, San Diego1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors15
Rare Diseases6
Metabolic Diseases4
Sphingolipidoses4
Genetic Diseases, Inborn3
Wolman Disease3
Adrenoleukodystrophy2
Anemia, Sickle Cell2
Bone Marrow Failure Disorders2
Gaucher Disease2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.